Halting the Epidemic of Addiction and Loss Act of 2025 This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration. Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.
Have questions about this legislation?
Our AI can explain provisions, analyze impacts, and answer questions in plain English.
Already have an account? Sign in
Make your voice heard on this bill.
Upgrade to Plus to generate an AI letter and send it to your House representative.
Get an instant AI-powered breakdown of this bill — what it does, who it affects, and what matters.
Create free accountAlready have an account? Sign in
Hear what historical figures and modern thinkers might say about this legislation.
Founding Fathers
Historical Leaders
Modern Thinkers
See how Jefferson, Churchill, or Einstein would react to this bill.
Create free accountAlready have an account? Sign in